ATC Group: V08AB04 Iopamidol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08AB04 in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08A X-ray contrast media, iodinated
4 V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
5 V08AB04 Iopamidol

Active ingredients in V08AB04

Active Ingredient Description
Iopamidol

Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media.

Related product monographs

Title Information Source Document Type  
GASTROMIRO Solution for oral or rectal administration Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ISOVUE 200/250/300/370 Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
NIOPAM Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Brazil (BR)

Canada (CA)

Croatia (HR)

Ecuador (EC)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Lithuania (LT)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.